Compare INVH & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INVH | SPRC |
|---|---|---|
| Founded | 2012 | 2004 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2B | 4.0M |
| IPO Year | 2016 | 2014 |
| Metric | INVH | SPRC |
|---|---|---|
| Price | $24.42 | $4.00 |
| Analyst Decision | Buy | |
| Analyst Count | 18 | 0 |
| Target Price | ★ $32.44 | N/A |
| AVG Volume (30 Days) | ★ 6.4M | 76.3K |
| Earning Date | 04-29-2026 | 03-23-2026 |
| Dividend Yield | ★ 4.83% | N/A |
| EPS Growth | ★ 29.73 | N/A |
| EPS | ★ 0.96 | N/A |
| Revenue | ★ $2,729,296,000.00 | N/A |
| Revenue This Year | $3.21 | N/A |
| Revenue Next Year | $2.64 | N/A |
| P/E Ratio | $25.88 | ★ N/A |
| Revenue Growth | ★ 4.21 | N/A |
| 52 Week Low | $24.25 | $0.23 |
| 52 Week High | $35.80 | $8.90 |
| Indicator | INVH | SPRC |
|---|---|---|
| Relative Strength Index (RSI) | 35.31 | 58.57 |
| Support Level | $24.25 | $4.00 |
| Resistance Level | $27.65 | $4.85 |
| Average True Range (ATR) | 0.47 | 0.47 |
| MACD | -0.04 | -0.16 |
| Stochastic Oscillator | 7.02 | 32.34 |
Invitation Homes owns a portfolio of over 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $350,000 and generally less than 1,800 square feet. The portfolio is spread across 17 target markets that feature high employment and household formation growth with over 70% of the portfolio in the Western US and Florida; 15 of the 17 markets featuring average rents lower than homeownership costs.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.